# Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer

> **NCT05059379** · PHASE3 · RECRUITING · sponsor: **Fudan University** · enrollment: 1650 (estimated)

## Conditions studied

- Breast Cancer
- Radiotherapy; Complications
- Effect of Radiation Therapy

## Interventions

- **RADIATION:** Entire supraclavicular lymph node radiotherapy
- **RADIATION:** Medial supraclavicular lymph node radiotherapy

## Key facts

- **NCT ID:** NCT05059379
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-20
- **Primary completion:** 2026-08
- **Final completion:** 2027-08
- **Target enrollment:** 1650 (ESTIMATED)
- **Last updated:** 2021-10-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05059379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05059379, "Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05059379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*